341.01
前日終値:
$339.59
開ける:
$339.49
24時間の取引高:
614.05K
Relative Volume:
0.72
時価総額:
$24.00B
収益:
$3.22B
当期純損益:
$542.70M
株価収益率:
45.59
EPS:
7.4805
ネットキャッシュフロー:
$458.00M
1週間 パフォーマンス:
+3.90%
1か月 パフォーマンス:
-5.01%
6か月 パフォーマンス:
+47.55%
1年 パフォーマンス:
+42.53%
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services Inc
|
341.01 | 23.31B | 3.22B | 542.70M | 458.00M | 7.4805 |
|
ISRG
Intuitive Surgical Inc
|
353.33 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
165.70 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
68.94 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
39.28 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
211.00 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 開始されました | Barclays | Equal Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
WST Maintains Rating by Evercore ISI Group -- Price Target Raised to $425 - GuruFocus
WEST PHARMACEUTICAL SERVICES INC : EVERCORE ISI RAISES TARGET PRICE TO $425 FROM $410 - Bitget
BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating - marketscreener.com
Weiss Asset Management LP Invests $1.99 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Renaissance Technologies LLC Has $52.55 Million Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical stock trades near record levels as injectable packaging demand supports growth - Ad-hoc-news.de
Arrowstreet Capital Limited Partnership Purchases 210,112 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia - MarketBeat
West Pharmaceutical stock holds recent gains as investors weigh steady growth and guidance - AD HOC NEWS
West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan - Yahoo Finance UK
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
ETFs Investing in West Pharmaceutical Services, Inc. Stocks - TradingView
West Pharmaceutical Services, Inc. Revenue Breakdown – MIL:1WST - TradingView
What Does Eric Green's Retirement Mean for West Pharmaceutical Services - Kavout | AI
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock trades steady as investors digest stronger 2025 guidance and recent margin - AD HOC NEWS
West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV - MarketBeat
Epoch Investment Partners Inc. Acquires 39,745 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services Inc (WST) a Bargain After 7.7% D - GuruFocus
West Pharmaceutical Services (WST) Receives a Buy from Barclays - The Globe and Mail
West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical lifts guidance on HVP-driven surge - The Globe and Mail
West Pharmaceutical Services, Inc. (WST) Earnings Dates, Call Summary & Reports - TipRanks
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - Yahoo Finance
West Pharmaceutical Services, Inc. (WPS) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Securities Class Action Lawsuit Filed Against West Pharmaceutical - The National Law Review
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (WST) and Thermo Fisher (TMO) - The Globe and Mail
West Pharmaceutical Services, Inc. (WPS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services Slides as Investors Digest a Post-Earnings Surge - Quiver Quantitative
West Pharmaceutical Services Q2 2026 Earnings: Revenue, Net Income, and Financial Highlights - Minichart
Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $410 - Moomoo
WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook - Yahoo Finance
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating - marketscreener.com
West Pharmaceutical beats 2Q26 estimates, raises full-year sales and EPS guidance. - Pluang
West Pharmaceutical Delivers Another BeatBut The Real Story Is The Mix Shift (NYSE:WST) - Seeking Alpha
Sei Investments Co. Has $132.65 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical: Q2 Earnings Snapshot - theheraldreview.com
West Pharmaceutical Earnings: Another Strong Quarter and Upward Guidance Revision - Morningstar
West Pharmaceutical Services Inc. Stock Slips 7.7%, Underperforms Peers - Bitget
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical stock trades steady as recent earnings highlight margin resilience - Ad-hoc-news.de
West Pharmaceutical Services, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:WST) 2026-07-24 - Seeking Alpha
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
West Pharmaceutical Services Inc (WST) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Option Exercise |
83.47 |
2,817 |
235,135 |
19,645 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Sale |
305.20 |
2,817 |
859,753 |
16,828 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Option Exercise |
173.22 |
896 |
155,205 |
2,419 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Sale |
300.67 |
896 |
269,399 |
1,523 |
大文字化:
|
ボリューム (24 時間):